Cross-Sectional and Prospective Associations Between Proinsulin and Cardiovascular Disease Risk Factors in a Population Experiencing Rapid Cultural Transition
- Anthony J.G. Hanley, PHD12,
- Gail McKeown-Eyssen, PHD1,
- Stewart B. Harris, MD3,
- Robert A. Hegele, MD4,
- Thomas M.S. Wolever, MD5,
- Jeremy Kwan, MSC6,
- Philip W. Connelly, PHD7 and
- Bernard Zinman, MD28
- 1Department of Public Health Sciences, University of Toronto, Toronto
- 2Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto
- 3Centre for Studies in Family Medicine, University of Western Ontario
- 4Robarts Research Institute, London
- 5Department of Nutritional Sciences and the
- 6Banting and Best Diabetes Centre, University of Toronto, Toronto
- 7Departments of Medicine, Biochemistry, and Laboratory Medicine and Pathobiology, St. Michael’s Hospital, University of Toronto, Toronto
- 8Division of Endocrinology and Metabolism, Mt. Sinai Hospital and University Health Network, Toronto, Ontario, Canada
Abstract
OBJECTIVE—To examine cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors using data from a population-based study of type 2 diabetes among Native Canadians.
RESEARCH DESIGN AND METHODS—Between 1993 and 1995, 72% of eligible members of a Native Canadian community participated in a baseline diabetes prevalence survey. Fasting samples were collected for glucose, C-peptide, proinsulin, lipids, and apolipoproteins. A 75-g oral glucose tolerance test was administered, and a second sample for glucose was drawn after 120 min. Blood pressure and waist circumference were determined. In the present study, subjects with normal glucose tolerance (NGT) (n = 505) and impaired glucose tolerance (IGT) (n = 74) were included in cross-sectional analyses. In 1998, 95 individuals who had IGT or NGT at baseline with an elevated 2-h glucose concentration (≥7.0 mmol/l) participated in a follow-up evaluation using the protocol used at baseline. Cross-sectional and prospective associations between proinsulin and cardiovascular risk factors were assessed using correlation and multiple linear regression analyses.
RESULTS—After adjustment for covariates including age, sex, C-peptide, waist circumference, and glucose tolerance status, fasting proinsulin concentration was significantly associated with concurrently measured lipid and apolipoprotein concentrations (triglycerides: r = 0.18, P < 0.0001; total cholesterol: r = 0.10, P = 0.02; LDL cholesterol: r = 0.11, P = 0.01; HDL cholesterol: r = −0.16, P = 0.0002; apolipoprotein (apo) B: r = 0.17, P < 0.0001; apoAI: r = −0.11, P = 0.008). In the adjusted prospective analysis, baseline triglycerides, HDL cholesterol, and apoB were associated with changes over time in proinsulin (r = 0.23, P = 0.04; r = −0.30, P = 0.01; r = 0.23, P = 0.04; respectively).
CONCLUSIONS—These results confirm previously reported cross-sectional associations between proinsulin and lipid concentrations. In addition, an unexpected association between baseline lipids and proinsulin change was documented.
- apo, apolipoprotein
- BP, blood pressure
- CVD, cardiovascular disease
- FFA, free fatty acid
- GTS, glucose tolerance status
- IGT, impaired glucose tolerance
- NGT, normal glucose tolerance
- OGTT, oral glucose tolerance test
Footnotes
-
Address correspondence and reprint requests to Bernard Zinman, MD, Division of Endocrinology and Metabolism, Mt. Sinai Hospital, 600 University Ave., Suite 782, Toronto, Ontario, M5G 1X5, Canada. E-mail: zinman{at}mshri.on.ca.
Received for publication 22 December 2000 and accepted in revised form 20 March 2001.
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.














